Treating rheumatoid arthritis using fibroblast-activated protein-α-responsive micelles through a cascade control program.

Rheumatoid arthritis (RA), a chronic autoimmune disorder affecting 1% globally, urgently demands advanced therapies to overcome the systemic toxicity and limited efficacy of conventional glucocorticoids like dexamethasone (Dex). In this study, we con…

Preview only. Read the full abstract at the source